- Leading European tech company expands investor base with listing on Euronext
- Market capitalisation of €307 million
- 62nd listing on Euronext in 2025
Euronext today congratulates Materialise, a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, on its listing on Euronext Brussels (ticker code: MTLS), complementing its existing Nasdaq listing of its American depositary shares (ADSs).
Founded in 1990 and headquartered in Leuven, Belgium, Materialise has been at the forefront of 3D printing technology for more than three decades. The company combines its expertise in software and additive manufacturing to empower customers across industries, helping them address real-world challenges and develop innovative solutions of the future.
Materialise’s listing on Euronext will further strengthen its international profile and expand its investor base among European investors. This listing will also support future growth through increased operational flexibility.
At the opening of the market day, the share price was €5.197 per share, giving the company a market value of €307 million this morning.
Brigitte de Vet, CEO of Materialise said: “Pursuing an additional listing on Euronext Brussels is a natural step in broadening our investor base while continuing to build on our global growth strategy. By aligning our roots with our global ambitions, we aim to create long-term value for shareholders and support innovation across industries from healthcare to aerospace, and beyond.”
Caption: Fried Vancraen, co-founder of Materialis, Brigitte de Vet, CEO of Materialise, and her team rang the bell during a ceremony this morning to celebrate the listing of Materialise.
